Brief: Freeline Therapeutics reports Q2 results

Freeline Therapeutics Holdings

09/08/2022 12:38

Aug 9 (Reuters) - Freeline Therapeutics Holdings PLC
 FRLN.O :
    * FREELINE REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
BUSINESS HIGHLIGHTS
    * FREELINE THERAPEUTICS HOLDINGS PLC- QTRLY CASH AND CASH
EQUIVALENTS WERE $90.0 MILLION AS OF JUNE 30, 2022
    * FREELINE THERAPEUTICS HOLDINGS- EXPECTS CURRENT LEVEL OF
CASH
AND CASH EQUIVALENTS WILL ENABLE CO TO FUND OPERATING EXPENSES
INTO SECOND HALF OF 2023

Source text for Eikon:  ID:nGNX84zpMl 
Further company coverage:  FRLN.O